Today's Perilous Reversal Stock: Vivus (VVUS)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified Vivus ( VVUS) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Vivus as such a stock due to the following factors:

  • VVUS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $19.7 million.
  • VVUS has traded 1.6 million shares today.
  • VVUS is down 3.9% today.
  • VVUS was up 12.4% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in VVUS with the Ticky from Trade-Ideas. See the FREE profile for VVUS NOW at Trade-Ideas

More details on VVUS:

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. Currently there is 1 analyst that rates Vivus a buy, 4 analysts rate it a sell, and 2 rate it a hold.

The average volume for Vivus has been 1.4 million shares per day over the past 30 days. Vivus has a market cap of $396.3 million and is part of the health care sector and drugs industry. The stock has a beta of 1.80 and a short float of 38.2% with 7.22 days to cover. Shares are down 57.8% year-to-date as of the close of trading on Tuesday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Insider Trading Alert - MAR, EVER And VVUS Traded By Insiders

Insider Trading Alert - MDSO, KAI And VVUS Traded By Insiders

Insider Trading Alert - OMAM, CBOE And VVUS Traded By Insiders

Insider Trading Alert - SBCF, VVUS And ACN Traded By Insiders

Vivus (VVUS) Strong On High Relative Volume Today